Table 1

Prevalence (and 95% confidence intervals) of risk factors in the adult population of Seychelles

Men

Women

Population aged 25–64*




25–34

35–44

45–54

55–64

25–34

35–44

45–54

55–64

Men

Women

Total


Smoking

30.2

32.1

31.2

29.3

4.0

4.0

3.9

3.3

30.8

3.9

17.4

22.7–38.8

24.7–40.5

24.4–38.9

22.6–37.1

1.8–8.7

1.9–8.1

1.9–7.9

1.5–7.2

27.0–34.9

2.6–5.7

15.3–19.7

Overweight (BMI ≥25 kg/m2)

41.3

55.2

63.3

50.7

55.0

67.6

76.2

83.4

52.0

68.3

60.1

33.0–50.1

46.7–63.5

55.5–70.5

42.7–58.6

46.9–62.9

60.3–74.1

69.5–81.9

77.3–88.2

47.7–56.2

64.5–71.8

57.2–62.9

Obesity (BMI ≥30 kg/m2)

9.5

14.9

22.8

14.7

22.8

37.5

39.8

48.1

15.0

35.2

25.1

5.5–16.1

9.8–22.1

16.9–30.0

9.8–21.3

16.8–30.3

30.6–44.9

32.9–47.1

40.9–55.4

12.3–18.3

31.6–38.8

22.8–27.5

HBP grade ≥1 (≥140/90 mmHg)

20.6

33.6

49.4

64.7

6.0

19.9

39.2

48.6

38.4

24.8

31.6

14.4-28-6

26.1–42.0

41.6–57.2

56.7-71-9

3.2–11.2

14.6–26,5

32.3–46.5

41.4–55.9

34.6–42.3

22.0–27.9

29.1–34.2

HBP grade ≥2 (≥160/100 mmHg)

5.6

7.5

22.2

24.7

1.3

5.1

16.0

18.8

13.2

8.8

11.0

2.7–11.2

4.1–13.4

16.3–29.3

18.4–32.2

0.3–5.2

2.7–8.6

11.3–22.1

13.7–25.2

10.8–16.1

7.0–10.8

9.4–12.8

Current treatment for HBP

5.6

14.9

32.9

46.0

6.0

18.2

37.6

58.6

21.4

25.6

23.5

2.7–11.2

9.8–22.1

26.5–40.7

28.2–54.1

3.2–11.2

13.1–24.6

30.8–44.9

51.2–65.5

18.5–24.6

22.8–28.6

21.4–25.7

HBP grade ≥1 or treatment

23.0

38.8

56.3

72.7

10.1

30.1

51.9

70.2

43.6

35.5

39.6

15.5–31.2

30.9–47.4

48.5–63.9

65.0–79.2

6.1–16.1

23.8–37.3

44.6–59.2

63.1–76.4

40.0–47.6

32.4–38.8

36.9–42.3

TC borderline or high (≥5.2 mmol/l)

41.3

55.2

57.6

53.3

36.2

48.3

60.2

69.6

51.1

50.8

51.0

33.0–50.0

46.7–63.5

49.7–65.1

45.3–61.2

28.9–44.3

41.0–55.7

52.9–67.1

62.5–75.9

46.8–55.3

47.0–54.6

48.1–53.8

TC high (≥6.2 mmol/)l

17.5

31.3

29.8

26.7

16.1

14.8

32.0

53.6

25.8

25.7

24.2

11.7–25.2

24.0–39.7

23.1–37.4

20.2–34.4

11.0–23.0

10.2–20.8

25.6–39.2

46.3–60.7

22.3–29.7

22.7–28.9

23.4–28.3

HDL-C low (<1.0 mmol/l)

19.8

31.3

28.5

20.0

14.8

12.5

20.4

21

25.2

16.5

20.8

13.7–27.8

24.0–39.7

22.0–36.1

14.3–27.2

10.0–21.5

8.4–18.3

15.2–27.0

15.7–27.6

21.6–29.1

13.8–19.5

18.6-23-3

Diabetes (FBG≥7.0 mmol/l)

0.8

9.7

12.7

22.0

2.0

4.6

11.6

26.5

9.6

9.0

9.3

0.1–5.5

5.7–16.0

8.3–18.9

16.1–29.3

0.6–6.1

2.3–8.9

7.7–17.2

20.6–33.4

7.6–12.1

7.3–11.2

7.9–10.9

Metabolic syndrome

4.9

19.4

29.1

28.5

9.4

21.6

36.1

48.0

18.7

25.5

22.1

2.2–10.5

13.3–27.0

22.5–36.7

21.7–36.4

5.6–15.3

16.1–28.3

29.4–43.4

40.8–55.4

15.7–21.9

22.5–28.7

20.0–24.3


HBP: high blood pressure; TC: total cholesterol; HDL-C: high density lipoprotein cholesterol; FBG: fasting blood glucose.

* Overall estimates are adjusted to the distribution of the new World Health Organization standard population (19)

Bovet et al. BMC Public Health 2006 6:9   doi:10.1186/1471-2458-6-9

Open Data